NICE Scientific Advice team
About NICE scientific advice
NICE Scientific Advice (SA) was established in 2009. We provide a fee-for-service advice to pharmaceutical companies and manufacturers of medical technologies.
We review development plans for their products to ensure they produce relevant evidence for future submission to NICE. We engage with the regulators to offer advice alongside the European Medicines Agency (EMA) and Medicines and Healthcare Products Regulatory Agency (MHRA).
Seren Phillips, Associate Director
Seren Phillips joined NICE in January 2002 as Associate Director for the Technology Appraisals Programme where she was responsible for the delivery of a portfolio of Technology Appraisals. Prior to joining NICE, she worked for GlaxoSmithKline and she has extensive experience in the pharmaceutical industry in a variety of roles in research, clinical research and health outcomes in the UK, France and the US.
Dr Leeza Osipenko, Senior Scientific Adviser
Leeza joined the Scientific Advice team in March 2012. Prior to her appointment Leeza worked at a public sector consultancy, Matrix Evidence, as Principal Economist where she led a number of economic modelling projects for the NICE Centre for Public Health Excellence and other public sector organisations. Between 2005 and 2009 Leeza worked at the University of Warwick Medical School as a Senior Research Fellow, conducting health economic evaluation of non-invasive prenatal diagnostic technologies. Leeza has a solid research and consulting background in health technology assessment and economic modelling.
Education: PhD in Systems Engineering, Stevens Institute of Technology (US); MSc in Information Technology, Syracuse University (US); BA in Economics, Denison University (US).
Emily Crowe, Technical Adviser
Emily joined NICE Scientific Advice as an analyst in May 2012. Previously, she coordinated the MRC Network of Hubs for Trials Methodology Research, a UK network to improve the design, conduct, and analysis of clinical trials. From 2006-2009, she worked as a research fellow in NICE guideline development at the Royal College of Physicians, where she was the analyst on three NICE guidelines (Chronic Kidney Disease, Acute Coronary Syndrome, and Chronic Obstructive Pulmonary Disease). She obtained her PhD in biochemistry at The University of British Columbia, Canada (2003), and did postdoctoral research in immune cell biology at the National Institute of Medical Research, London.
Dr Elangovan Gajraj, Technical Adviser
Eli graduated in medicine from St John's Medical College, Bangalore, India. Following this he worked as a research assistant in physiology, studying the physiology of adaptation to chronic stress. He then trained in paediatrics in India and the UK, achieving membership of the Royal College of Paediatrics and Child Health, and continued to train as a paediatrician, specialising in the acute and intensive care of neonates and children. Eli has a Masters in Health Policy, Planning and Financing from the London School of Hygiene and Tropical Medicine and the London School of Economics. He joined NICE in 2006 as an analyst in the Technology Appraisals Programme, focusing on the appraisal of interventions in haematological malignancies and diabetes and has worked with the Scientific Advice Programme since 2009. Eli acts as the lead on issues to do with methodology development within the team, participates in technical workshops and undertakes educational outreach as a lecturer on Masters programmes.
Richard Chivers, Project Manager
Richard has an honours degree in pharmacology from the University of Leeds and has managed all NICE Scientific Advice projects since September 2010. Prior to this, Richard worked on the development, promotion and launch of NHS Evidence at NICE.
Philippa Wood, Project Coordinator
Philippa has an honours degree in English and Spanish from the University of Manchester. Philippa joined the Clinical Audit team at NICE in 2010 and then moved to NICE Scientific Advice in 2011.
This page was last updated: 26 November 2013